Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 2;7(1):5.
doi: 10.3390/biology7010005.

Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions

Affiliations
Review

Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions

Vinit Shanbhag et al. Biology (Basel). .

Abstract

DNA polymerases are essential for genome replication, DNA repair and translesion DNA synthesis (TLS). Broadly, these enzymes belong to two groups: replicative and non-replicative DNA polymerases. A considerable body of data suggests that both groups of DNA polymerases are associated with cancer. Many mutations in cancer cells are either the result of error-prone DNA synthesis by non-replicative polymerases, or the inability of replicative DNA polymerases to proofread mismatched nucleotides due to mutations in 3'-5' exonuclease activity. Moreover, non-replicative, TLS-capable DNA polymerases can negatively impact cancer treatment by synthesizing DNA past lesions generated from treatments such as cisplatin, oxaliplatin, etoposide, bleomycin, and radiotherapy. Hence, the inhibition of DNA polymerases in tumor cells has the potential to enhance treatment outcomes. Here, we review the association of DNA polymerases in cancer from the A and B families, which participate in lesion bypass, and conduct gene replication. We also discuss possible therapeutic interventions that could be used to maneuver the role of these enzymes in tumorigenesis.

Keywords: 3′-5′ exonuclease; DNA polymerase; DNA polymerase and cancer; base excision repair; cancer; mismatch repair; replication fork; therapy for mismatch repair deficient cancers; translesion DNA synthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structures of family A DNA polymerases. (A) superposition of the ternary complex crystal structures of polymerase θ [63] (green, tetrahydrofuran-ddATP; cyan, dTMP-ddATP) and the ternary complex of KlenTaq (magenta, Protein Data Bank file 1QSY, Li et al., [83]); (B) This figure shows three different conformations of O-helix. Depending upon the template, polymerase θ assumes different O-helix conformation to conduct translesion synthesis; (C) close-up of the active site in three crystal structures. Only metal B, which is Ca2+ (shown as green ball) was seen in the crystal structures of polymerase θ. Metal A (pink ball) as seen in the crystal structure of KlenTaq is also shown here. The three active site residues of KlenTaq (D610, D785 and E786) are also shown in this figure. For simplicity, the residues positions of only KlenTaq are marked.

Similar articles

Cited by

References

    1. Tubbs A., Nussenzweig A. Endogenous DNA damage as a source of genomic instability in cancer. Cell. 2017;168:644–656. doi: 10.1016/j.cell.2017.01.002. - DOI - PMC - PubMed
    1. Lindahl T., Barnes D.E. Repair of endogenous DNA damage. Cold Spring Harb. Symp. Quant. Biol. 2000;65:127–133. doi: 10.1101/sqb.2000.65.127. - DOI - PubMed
    1. Lindahl T., Wood R.D. Quality control by DNA repair. Science. 1999;286:1897–1905. doi: 10.1126/science.286.5446.1897. - DOI - PubMed
    1. Bessman M.J., Kornberg A., Lehman I.R., Simms E.S. Enzymic synthesis of deoxyribonucleic acid. Biochim. Biophys. Acta. 1956;21:197–198. - PubMed
    1. Kornberg A. Biologic synthesis of deoxyribonucleic acid. Science. 1960;131:1503–1508. doi: 10.1126/science.131.3412.1503. - DOI - PubMed

LinkOut - more resources